145 related articles for article (PubMed ID: 33765933)
1. Associations between essential medicines and health outcomes for cardiovascular disease.
Steiner L; Fraser S; Maraj D; Persaud N
BMC Cardiovasc Disord; 2021 Mar; 21(1):151. PubMed ID: 33765933
[TBL] [Abstract][Full Text] [Related]
2. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
[TBL] [Abstract][Full Text] [Related]
3. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
4. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.
Wirtz VJ; Kaplan WA; Kwan GF; Laing RO
Circulation; 2016 May; 133(21):2076-85. PubMed ID: 27217433
[TBL] [Abstract][Full Text] [Related]
5. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
6. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study.
Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N
Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706
[TBL] [Abstract][Full Text] [Related]
8. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
Perumal-Pillay VA; Suleman F
BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
[TBL] [Abstract][Full Text] [Related]
9. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
[TBL] [Abstract][Full Text] [Related]
10. Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria.
Orubu ESF; Robert FO; Samuel M; Megbule D
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii20-iii26. PubMed ID: 31816074
[TBL] [Abstract][Full Text] [Related]
11. Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries.
Barr R; Robertson J
Pediatr Blood Cancer; 2016 Feb; 63(2):287-91. PubMed ID: 26375626
[TBL] [Abstract][Full Text] [Related]
12. Availability of medicines in public sector health facilities of two North Indian States.
Prinja S; Bahuguna P; Tripathy JP; Kumar R
BMC Pharmacol Toxicol; 2015 Dec; 16():43. PubMed ID: 26699711
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region.
Mehrtash H; Laing R; Wirtz VJ
East Mediterr Health J; 2018 Jul; 24(5):427-434. PubMed ID: 30043961
[TBL] [Abstract][Full Text] [Related]
14. Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries.
Kishore SP; Vedanthan R; Fuster V
J Am Coll Cardiol; 2011 May; 57(20):1980-7. PubMed ID: 21565635
[TBL] [Abstract][Full Text] [Related]
15. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
Osuafor NG; Ukwe CV; Okonta M
PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
[TBL] [Abstract][Full Text] [Related]
17. Access to medicines through health systems in low- and middle-income countries.
Ozawa S; Shankar R; Leopold C; Orubu S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii1-iii3. PubMed ID: 31816069
[TBL] [Abstract][Full Text] [Related]
18. Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.
McGettigan P; Henry D
PLoS Med; 2013; 10(2):e1001388. PubMed ID: 23424288
[TBL] [Abstract][Full Text] [Related]
19. Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala.
Anson A; Ramay B; de Esparza AR; Bero L
Global Health; 2012 Jul; 8():22. PubMed ID: 22747646
[TBL] [Abstract][Full Text] [Related]
20. Increasing access to quality anticancer medicines in low- and middle-income countries: the experience of Uganda.
Osinde G; Niyonzima N; Mulema V; Kyambadde D; Mulumba Y; Obayo S; Anecho E; Watera S; Constance M; Kadhumbula S; Orem J
Future Oncol; 2021 Jul; 17(21):2735-2745. PubMed ID: 33855863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]